Alto Neuroscience, Inc. (ANRO)
22.36
-1.93
(-7.95%)
USD |
NYSE |
Mar 17, 16:00
22.50
+0.14
(+0.63%)
Pre-Market: 20:00
Alto Neuroscience EPS Diluted (Quarterly) : -0.5069 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | -1.203 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | 0.111 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Replimune Group, Inc. | -0.7694 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.18M |
| Total Expenses (Quarterly) | 16.18M |
| Enterprise Value | 542.12M |
| Earnings Yield | -10.04% |
| Normalized Earnings Yield | -9.925 |